FDA awards Kuros Biosciences 510(k) approval for TLIF cage — 3 insights

Written by Eric Oliver | March 15, 2019 | Print  |

Kuros Biosciences received FDA 510(k) approval for its transforaminal lumbar interbody fusion cage.

What you should know:

1. Kuros developed the TLIF cage for use with its spinal fusion product candidate KUR-113. The FDA cleared the cage for use in the lumbar spine with autograft and/or allograft.

2. With the approval, Kuros will begin a clinical trial studying the two products in patients.

3. The TLIF cage comes in several sizes and includes instrumentation.

More articles on devices: 
Humana launches bundled payments for spinal fusions at 4 practices, expands joint replacement program
29 spine, neurosurgeons on the move this year so far
Is price transparency positive or negative for spine? 3 surgeons weigh in

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months